logo

Shariatga muvofiqlik sharhi

Halol

Starling Oncology, Inc. (STLN) hozirda Akinda shariat skriningi (AAOIFI) bo'yicha Halol deb tasniflanadi.

Starling Oncology, Inc. haqida

Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population.

Starling Oncology, Inc. (STLN) Healthcare sektorida, Medical - Care Facilities sohasida faoliyat yuritadi.

Nega halol: aksiya AAOIFI ning uchala tekshiruvidan o'tadi. Nomuvofiq daromad — 0.00% (chegara 5%), foizli qarz — 13.22% (chegara 30%), foizli qimmatli qog'ozlar va aktivlar — 5.73% (chegara 30%).

Kompaniya faoliyati
0.00%Chegara 5%Muvaffaq
Foizli qarz
13.22%Chegara 30%Muvaffaq
Foizli qimmatli qog‘ozlar va aktivlar
5.73%Chegara 30%Muvaffaq
Dividendlarni poklash
0.00%Xayriyaga beriladigan dividend ulushiPoklash kalkulyatori

Oxirgi yangilanish: 3-noy, 2026 · Skrining ma'lumot uchun; bu fatvo emas. Shaxsiy maslahat uchun malakali olim bilan maslahatlashing.

STLN stock chart by TradingView

Kontentni ko'rish uchun tizimga kiring

Asosiy ko'rsatkichlar

Kontentni ko'rish uchun tizimga kiring

Kontentni ko'rish uchun tizimga kiring

Kompaniya profili

Kontentni ko'rish uchun tizimga kiring

Tez-tez beriladigan savollar

Starling Oncology, Inc. (STLN) bo‘yicha qisqa javoblar. Akinda skrining yorlig‘i: Halol.

Healthcare sektoridagi boshqa halol aksiyalar